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Introduction

2
Preterm birth (PTB), defined as delivery less than 37 weeks of gestation, accounts for 3 approximately 11% of all live births worldwide (Blencowe et al., 2013) and is associated 4 with 70% of all neonatal mortality and morbidity (Goldenberg et al., 2008) . The morbidity 5 and mortality associated with PTB incurs significant human and financial costs (Petrou, 6 2005); the annual societal costs associated with PTB in the USA was estimated to be $26.2 (DiGiulio et al., 2010 , Kim et al., 2009 , Romero et al., 2001 . Activation of pathogen 16 recognition receptors by bacteria, most commonly originating and ascending from the vagina 17 (DiGiulio, 2012 , DiGiulio et al., 2010 , Jones et al., 2009 , initiates a cascade of pro-18 inflammatory events, resulting in histologic chorioamnionitis and elevated amniotic fluid
19
(AF) concentrations of pro-inflammatory cytokines, chemokines and prostaglandins 20 (Agrawal et al., 2012 , Elovitz et al., 2003 , Romero et al., 2001 . These events trigger uterine 21 contractions and initiation of PTL. In the most severe cases, IUI can lead to fetal 22 inflammatory response syndrome (FIRS) (reviewed in (Gotsch et al., 2007) ) characterised by 23 increased fetal expression of chemokines and cytokines and damage to the cardiovascular, 24 4 pulmonary, hepatic, gastrointestinal and neurological systems (Fawke, 2007 , Jobe, 2012 , 1 Lahra et al., 2009 , Shatrov et al., 2010 , Viscardi et al., 2004 .
3
The administration of antibiotics to women for the treatment or prevention of preterm labour 4 has been shown to have little effect on reducing rates of preterm birth or neonatal morbidity 5 and mortality (Joergensen et al., 2014a , Kenyon et al., 2008a , 2008b , Kenyon et al., 2001a 2001b, Simcox et al., 2007) . As maternal and fetal inflammation associated with IUI is 7 usually well established at presentation with PTL, effective treatment is required to both 8 combat the infection and reduce the associated inflammatory response (Keelan, 2011 , Rinaldi 9 et al., 2011 . In an important proof-of-principle study, co-treatment of a high risk cohort of 10 women with bacterial vaginosis with N-acetyl cysteine (NAC), a non-specific inhibitor of 11 inflammatory signalling pathways, was shown to reduce the incidence of PTB, increase birth 12 weight and reduce neonatal morbidity/mortality over and above the effects of 17- Non-steroidal anti-inflammatory drugs (NSAIDS) were once commonly prescribed in 18 pregnancy to treat fever, pain and inflammation, but their use has declined due to adverse 19 effect profiles (Kaplan et al., 1994 , Kaplan et al., 2013 , Nakhai-Pour et al., 2011 . Cytokine-20 suppressive anti-inflammatory drugs (CSAIDs) are a novel category of anti-inflammatory 21 drugs that specifically target inflammatory signalling pathways (e.g. NF-κB or MAPK 22 pethways), without the adverse and/or non-specific effects of NSAIDs (Griswold et al., 1993, 23 Keelan, 2011). We recently compared the anti-inflammatory effects of NAC and three
24
CSAIDs on stimulated human and ovine gestational membranes and found two drugs were 25 effective at suppressing cytokine and prostaglandin production in vitro (Stinson et al., 2014) The size and the gestational length (approximately 147 days) of sheep enables longitudinal 13 pregnancy studies including non-invasive amniotic fluid sampling under ultrasound guidance,
14
and surgical interventions such as long-term catheterization (reviewed in (Kemp et al., 2010) .
15
Intraamniotic LPS administration in sheep results in chorioamnionitis, elevated 16 proinflammatory cytokine expression in the amnion/chorion, increased cytokine and 17 prostaglandin levels in the amniotic fluid and fetal lung inflammation (Kallapur et al., 2001) 18 mimicking that observed in the human condition and making it a good experimental model with lesser or negligible effects on the fetus and mother. (Kallapur et al., 2007 , Saito et al., 2014 (Sandlin et al., 2014 , 3 Tomoda et al., 1985 . OxZnl was administered to yield an approximate concentration of 5 4 μM in AF. The target doses were chosen based on concentration-response data from our 5 preliminary and published fetal membrane studies; these studies indicated that concentrations 6 of 20 µM TPCA-1 and 5 µM OxZnl are close to maximally effective in suppressing cytokine 7 production without exerting toxicity (De Silva et al., 2010 , Stinson et al., 2014 determined by ELISA as previously described (Saito et al., 2014) . Samples were analysed 3 undiluted for IL-6 and at 1:50 dilution for IL-8. The top standard for IL-6 was 8000 pg/ml 4 with a lower limit of detection of 150 pg/ml and average intra-assay coefficient of variability 5 (CV) of 8%. The top standard for IL-8 was 8000 pg/ml with a lower limit of detection of 25 6 pg/ml and CV of 10%. Quantification of PGE 2 in AF was performed using a prostaglandin LPS/CSAID samples at 1:20 dilution. The assay range PGE 2 was 10-1000 pg/ml with a CV 10 of 9%. Samples falling below the lower limits of detection were assigned the concentration 11 equivalent to the lower limit detected for statistical analysis. at low-power magnification and scored as previously described (Kemp et al., 2014) . The 10 scorer was blind to the group identity of the sections.
12
For fetal lung, scores were as follows: were only increased after 48 h for IL-8 (time factor p=0.010). IL-6 concentrations tended to 5 be highest in the LPS/vehicle group at 48 h, but were highly variable and the differences were 6 not statistically significant. IL-6 levels in the fetal circulation of CSAID treated animals were 7 low or non-detectable and not significantly different from LPS/vehicle ( Figure 4B ). et al., 2007 , Kallapur et al., 2001 , Polglase et al., 2010 , Saito et al., 2014 9 confirming data from earlier studies in simpler models. et al., 2014 , Menon et al., 2008 , Romero et al., 2014 OxZnl is a less well studied fungal inhibitor with specificity for mitogen-activated protein 4 kinase kinase kinase (7MAP3K7), also known as TGF-β-activated kinase 1 (TAK1) (Wu et 5 al., 2013) . This enzyme lies upstream of IKKβ in the NF-κB pathway and is also involved in 6 the p38MAPK signalling pathway; hence, it makes an ideal anti-inflammatory drug target. However, we did find evidence of lower circulating maternal IL-6 concentrations in the 2 CSAID-treated groups. Additional studies are needed to confirm this and ascertain the 3 mechanism by which this effect may be mediated.
FIRS (Kallapur
5
The primary limitation of this study was the small samples size. With a starting value of N=7 6 and a fetal loss rate of 18% we had only 4 animals left in the LPS/OxZnl group. Furthermore, In conclusion, prophylactic antibiotics given to women at high risk of IUI have had limited 19 success in preventing PTB or improving neonatal outcomes. This is likely due in part to the 20 choice and timing of antibiotic administered, the selection of patients deemed 'at risk', and 21 the pro-inflammatory nature of microbial lysis (Joergensen et al., 2014b , Kenyon et al., 22 2008a , 2008b , Kenyon et al., 2001a , 2001b , Simcox et al., 2007 
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The authors report no conflicts of interest. were measured and fetal organs were sampled. Individual scores are presented with median for each group. 
